Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector (Q36036225)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector
scientific article

    Statements

    Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector (English)
    0 references
    Peter Manilla
    Tessio Rebello
    Cathleen Afable
    Xiaobin Lu
    Vladimir Slepushkin
    Laurent M Humeau
    Kathy Schonely
    Gwendolyn K Binder
    Rob-Roy MacGregor
    Boro Dropulic
    1 January 2005

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit